PortView
Bright Minds Biosciences (DRUG) Stock Analysis
NASDAQHealthcareBiotechnology
What Bright Minds Biosciences does
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Key metrics
ETFs linked to DRUG
Broad-market and Healthcare sector ETFs an investor holding Bright Minds Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how DRUG fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze DRUG in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Bright Minds Biosciences?
- Bright Minds Biosciences trades under the ticker DRUG on NASDAQ.
- Which exchange is DRUG listed on?
- DRUG is listed on NASDAQ.
- What sector does Bright Minds Biosciences operate in?
- Bright Minds Biosciences is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze DRUG in a portfolio?
- PortView shows DRUG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.